{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:33:41Z","timestamp":1787070821021,"version":"build-2736575974"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:p>Cancer cachexia is a wasting syndrome resulting from decreased protein synthesis and increased protein degradation. Calpain-dependent cleavage of myofilament is the initial step of myofilament degradation and plays a critical role in muscle atrophy. Ghrelin is a multifunctional hormone known to improve protein synthesis and inhibit protein degradation. However, its mechanism of action is not fully understood. Here we investigated whether acylated ghrelin (AG) and unacylated ghrelin (UnAG) could protect against cancer cachexia in mice bearing CT26 colorectal adenocarcinoma. We found for the first time that both AG and UnAG could inhibit calpain activity in skeletal muscle of cancer cachectic mice. AG and UnAG also improved tumor-free body weight, grip strength, muscle mass, epididymal fat mass, and nutritional state in tumor-bearing (TB) mice. Moreover, AG and UnAG reduced serum tumor necrosis factor-\u03b1 concentration, increased Akt activity, and downregulated atrogin-1 expression in TB mice. Our results may contribute to the development of an AG\/UnAG-based therapy for cancer cachexia.<\/jats:p>","DOI":"10.4103\/cjp.cjp_59_20","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T05:15:59Z","timestamp":1603775759000},"page":"195-203","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Acylated and Unacylated Ghrelin Relieve Cancer Cachexia in Mice through Multiple Mechanisms"],"prefix":"10.4103","volume":"63","author":[{"given":"Xianliang","family":"Zeng","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sizeng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,10,27]]},"reference":[{"key":"R1-20250512","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"R2-20250512","doi-asserted-by":"crossref","first-page":"601434","DOI":"10.1155\/2011\/601434","article-title":"Cancer cachexia: mechanisms and clinical implications","volume":"2011","author":"Donohoe","year":"2011","journal-title":"Gastroenterol Res Pract"},{"key":"R3-20250512","doi-asserted-by":"crossref","first-page":"H1565","DOI":"10.1152\/ajpheart.00146.2010","article-title":"IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression","volume":"298","author":"Yoshida","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R4-20250512","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J Clin Oncol"},{"key":"R5-20250512","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.2527\/jas.2007-0395","article-title":"Myofibrillar protein turnover: the proteasome and the calpains","volume":"86","author":"Goll","year":"2008","journal-title":"J Anim Sci"},{"key":"R6-20250512","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.biocel.2013.05.032","article-title":"Muscle wasting in cancer","volume":"45","author":"Johns","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"R7-20250512","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.ajpath.2012.12.023","article-title":"Autophagic degradation contributes to muscle wasting in cancer cachexia","volume":"182","author":"Penna","year":"2013","journal-title":"Am J Pathol"},{"key":"R8-20250512","doi-asserted-by":"crossref","first-page":"547","DOI":"10.33549\/physiolres.933087","article-title":"The molecular mechanisms of calpains action on skeletal muscle atrophy","volume":"65","author":"Huang","year":"2016","journal-title":"Physiol Res"},{"key":"R9-20250512","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1517\/13543776.2011.568480","article-title":"Calpain inhibitors: a survey of compounds reported in the patent and scientific literature","volume":"21","author":"Donkor","year":"2011","journal-title":"Expert Opin Ther Pat"},{"key":"R10-20250512","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.abb.2015.07.011","article-title":"Calpain-dependent regulation of the skeletal muscle atrophy following unloading","volume":"584","author":"Shenkman","year":"2015","journal-title":"Arch Biochem Biophys"},{"key":"R11-20250512","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1113\/expphysiol.2006.035790","article-title":"Calpain activation causes a proteasome-dependent increase in protein degradation and inhibits the Akt signalling pathway in rat diaphragm muscle","volume":"92","author":"Smith","year":"2007","journal-title":"Exp Physiol"},{"key":"R12-20250512","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.biocel.2005.04.018","article-title":"Skeletal muscle hypertrophy and atrophy signaling pathways","volume":"37","author":"Glass","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"key":"R13-20250512","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1128\/MCB.00666-09","article-title":"Regulation of the intracellular localization of Foxo3a by stress-activated protein kinase signaling pathways in skeletal muscle cells","volume":"30","author":"Clavel","year":"2010","journal-title":"Mol Cell Biol"},{"key":"R14-20250512","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0092-8674(04)00400-3","article-title":"Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy","volume":"117","author":"Sandri","year":"2004","journal-title":"Cell"},{"key":"R15-20250512","first-page":"611","article-title":"Acylated and unacylated ghrelin impair skeletal muscle atrophy in mice","volume":"123","author":"Porporato","year":"2013","journal-title":"J Clin Invest"},{"key":"R16-20250512","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.3892\/or.2017.5396","article-title":"Calpain inhibitors ameliorate muscle wasting in a cachectic mouse model bearing CT26 colorectal adenocarcinoma","volume":"37","author":"Lin","year":"2017","journal-title":"Oncol Rep"},{"key":"R17-20250512","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1517\/14712598.2013.748031","article-title":"The hunger hormone ghrelin in cachexia","volume":"13","author":"Molfino","year":"2013","journal-title":"Expert Opin Biol Ther"},{"key":"R18-20250512","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.mce.2011.04.013","article-title":"Ghrelin and cancer","volume":"340","author":"Chopin","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"R19-20250512","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/B978-0-12-410473-0.00003-9","article-title":"The role of ghrelin in anorexia-cachexia syndromes","volume":"92","author":"Guillory","year":"2013","journal-title":"Vitam Horm"},{"key":"R20-20250512","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.nut.2008.06.013","article-title":"Emergence of ghrelin as a treatment for cachexia syndromes","volume":"24","author":"DeBoer","year":"2008","journal-title":"Nutrition"},{"key":"R21-20250512","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1007\/s00125-012-2671-5","article-title":"The ghrelin O-acyltransferase-ghrelin system reduces TNF-alpha-induced apoptosis and autophagy in human visceral adipocytes","volume":"55","author":"Rodriguez","year":"2012","journal-title":"Diabetologia"},{"key":"R22-20250512","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.mce.2011.12.021","article-title":"Des-acyl ghrelin exhibits pro-anabolic and anti-catabolic effects on C2C12 myotubes exposed to cytokines and reduces burn-induced muscle proteolysis in rats","volume":"351","author":"Sheriff","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"R23-20250512","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1210\/en.2013-1179","article-title":"Inhibition of cisplatin-induced lipid catabolism and weight loss by ghrelin in male mice","volume":"154","author":"Garcia","year":"2013","journal-title":"Endocrinology"},{"key":"R24-20250512","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/jcsm.12023","article-title":"Ghrelin prevents tumour- and cisplatin-induced muscle wasting: characterization of multiple mechanisms involved","volume":"6","author":"Chen","year":"2015","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R25-20250512","first-page":"533","article-title":"Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia","volume":"5","author":"Murphy","year":"2012","journal-title":"Dis Model Mech"},{"key":"R26-20250512","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: understanding the molecular basis","volume":"14","author":"Argiles","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"R27-20250512","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1002\/cncr.21013","article-title":"Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care--correlations with food intake, metabolism, exercise capacity, and hormones","volume":"103","author":"Fouladiun","year":"2005","journal-title":"Cancer"},{"key":"R28-20250512","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab"},{"key":"R29-20250512","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/MCO.0000000000000075","article-title":"Ghrelin: from discovery to cancer cachexia therapy","volume":"17","author":"Molfino","year":"2014","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"R30-20250512","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1002\/ijc.26298","article-title":"Myosin heavy chain is not selectively decreased in murine cancer cachexia","volume":"130","author":"Cosper","year":"2012","journal-title":"Int J Cancer"},{"key":"R31-20250512","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.biocel.2005.03.012","article-title":"Cellular signals activating muscle proteolysis in chronic kidney disease: A two-stage process","volume":"37","author":"Du","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"key":"R32-20250512","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/j.biocel.2005.05.009","article-title":"Post burn muscle wasting and the effects of treatments","volume":"37","author":"Pereira","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"key":"R33-20250512","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/mus.21893","article-title":"Calpain activity is increased in skeletal muscle from gastric cancer patients with no or minimal weight loss","volume":"43","author":"Smith","year":"2011","journal-title":"Muscle Nerve"},{"key":"R34-20250512","doi-asserted-by":"crossref","first-page":"E762","DOI":"10.1152\/ajpendo.90226.2008","article-title":"Calpain activity and muscle wasting in sepsis","volume":"295","author":"Smith","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R35-20250512","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1054\/bjoc.2001.1696","article-title":"Activation of Ca2+-dependent proteolysis in skeletal muscle and heart in cancer cachexia","volume":"84","author":"Costelli","year":"2001","journal-title":"Br J Cancer"},{"key":"R36-20250512","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2014.09.025","article-title":"Ghrelin relieves cancer cachexia associated with the development of lung adenocarcinoma in mice","volume":"743","author":"Tsubouchi","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"R37-20250512","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"},{"key":"R38-20250512","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1210\/en.2007-0016","article-title":"Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia","volume":"148","author":"DeBoer","year":"2007","journal-title":"Endocrinology"},{"key":"R39-20250512","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/MCO.0000000000000049","article-title":"Acylated and unacylated ghrelin administration to blunt muscle wasting","volume":"17","author":"Reano","year":"2014","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"R40-20250512","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/med.20010","article-title":"Cross-talk between skeletal muscle and adipose tissue: a link with obesity?","volume":"25","author":"Argiles","year":"2005","journal-title":"Med Res Rev"},{"key":"R41-20250512","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5493\/wjem.v3.i3.26","article-title":"Interplay of adipokines and myokines in cancer pathophysiology: Emerging therapeutic implications","volume":"3","author":"Dalamaga","year":"2013","journal-title":"World J Exp Med"},{"key":"R42-20250512","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/SPC.0b013e3282f34738","article-title":"Mechanisms to explain wasting of muscle and fat in cancer cachexia","volume":"1","author":"Argiles","year":"2007","journal-title":"Curr Opin Support Palliat Care"},{"key":"R43-20250512","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1126\/science.1198973","article-title":"Adipose triglyceride lipase contributes to cancer-associated cachexia","volume":"333","author":"Das","year":"2011","journal-title":"Science"},{"key":"R44-20250512","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jacl.2016.02.015","article-title":"Identification and characterization of two novel mutations in the LPL gene causing type I hyperlipoproteinemia","volume":"10","author":"Pingitore","year":"2016","journal-title":"J Clin Lipidol"},{"key":"R45-20250512","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1091\/mbc.e06-05-0402","article-title":"Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells","volume":"18","author":"Filigheddu","year":"2007","journal-title":"Mol Biol Cell"}],"container-title":["Chinese Journal of Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/CJP.CJP_59_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:37:09Z","timestamp":1787067429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/CJP.CJP_59_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.4103\/cjp.cjp_59_20","relation":{},"ISSN":["0304-4920","2666-0059"],"issn-type":[{"value":"0304-4920","type":"print"},{"value":"2666-0059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"2020-07-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}